Skip to main content

Scott John K Jr.'s Form 4 filing

Navidea Biopharmaceuticals, Inc. (NAVB) · filed Jun 15, 2023

Accession no.
0001437749-23-017587
Filed
Jun 15, 2023
Trade date
Jun 1-5, 2023
Filing delay
14 daysLate
Rule 10b5-1 plan
Not checked

This filing lists 2 non-derivative transactions and 2 derivative transactions. It was filed 14 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Scott John K Jr.CIK 0001753763Director, 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 1, 2023Series G Redeemable Preferred StockJOtherDisposed−990–F1–2,270Direct
Jun 5, 2023Common StockAGrant or awardAcquired+11,508,672–F2–19,555,832Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 1, 2023Common StockPPurchaseAcquired+11,508,672$100.00+$1,196,90011,969Direct
Jun 5, 2023Common StockCConversionDisposed−11,508,672$100.00−$1,196,9000Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Navidea entered into a Stock Exchange Agreement with the Reporting Person, pursuant to which he surrendered 990 shares of Series G Redeemable Preferred Stock, par value $.001 per share, and $68,853.22 of accrued and unpaid dividends thereon in exchange for 11,969 shares of Series J Convertible Preferred Stock, par value $.001 per share.

Referenced by the price of 1 transaction in Table I.

F2

Series J Convertible Preferred Stock, par value $.001 per share was converted into Common Stock.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)